NCT05390411
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
Enrolling by Invitation
NAAges 18+InterventionalTreatmentIndiana UniversityInvestigator-initiated
~1,463 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:SOCIAL HF
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of evaluated minoritized racial/ethnic patients and women patients receiving advanced therapies.
Measured over Up to 2 years
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesIndiana1
Study leadership
- Khadijah Breathett, MD, MS · PRINCIPAL_INVESTIGATOR · Indiana University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Proportion of evaluated minoritized racial/ethnic patients and women patients receiving advanced therapies.Up to 2 years
- Change in SOCIAL HF fidelity from time of training completion (month 2) to time study target has been reached (up to 2 years) and 6 months after reaching study target (up to 2.5 years)Month 2, up to 2 years, and up to 2.5 years
Evaluated as barriers, facilitators, and variability in adoption, reach, implementation and maintenance through structured interviews. Study target is defined as time 50 patients of color and 50 women have been evaluated for advanced heart failure therapies per center.